press
May 02, 2018 + Jessica Di Palo
5 Min read
Dr Christoph Kausch, Managing Partner at MTIP, talks to Biotech and Money about the firm’s ambitions and its commitment to environmental, social, and governance values.
Swiss healthcare-focused venture capital firm MTIP is in the process of building a portfolio of digital health and medical technologies companies after closing its first CHF60 million fund in 2017. Dr. Christoph Kausch, Founding Partner and Chief Executive Officer at MTIP, talks to Biotech and Money about the firm’s ambitions and its commitment to environmental, social, and governance values.
Download the article here.
fun fact: bioandtechnology got rebranded to LSX Leaders. visit their website to learn more: www.lsxleaders.com